EVIO, Inc. announced the appointment of Albert Lustig as President of the company, reporting to William Waldrop, EVIO Chief Executive Officer. Lustig’s primary responsibility will be to drive EVIO’s growth in both new and existing markets by developing and executing national and international sales and operational strategies. Lustig joins EVIO after completing a successful 30-year career at Pfizer Inc. Lustig joined Pfizer in 1986 as a Professional Sales Representative and quickly ascended to positions of increased responsibility, leading to State Director.
EVIO, Inc. is a diversified holding company. The Company provides analytical testing services to the agricultural and pharmaceutical industries, primarily for cannabis, hemp, and related products. The Company offers residential and commercial construction services. The Company also offers research and development and consulting services for participants in the cannabis and hemp industries. The Company tests products to verify the regulatory requirements for sale. Its subsidiaries include Smith Scientific Industries, LLC; Greenhaus Analytical Labs, LLC; Viridis Analytics, LLC; EVIO Labs OR, Inc.; C3 Labs, LLC; EVIO Labs Humboldt, LLC and Keystone Labs, Inc.